Nuvation Bio Inc. (NUVB-WT)

USD 0.24

(23.87%)

Total Assets Summary of Nuvation Bio Inc.

  • Nuvation Bio Inc.'s latest annual total assets in 2023 was 621.48 Million USD , down -7.54% from previous year.
  • Nuvation Bio Inc.'s latest quarterly total assets in 2024 Q2 was 594.79 Million USD , down -2.99% from previous quarter.
  • Nuvation Bio Inc. reported annual total assets of 672.14 Million USD in 2022, down -13.4% from previous year.
  • Nuvation Bio Inc. reported annual total assets of 776.15 Million USD in 2021, up 249.95% from previous year.
  • Nuvation Bio Inc. reported quarterly total assets of 613.12 Million USD for 2024 Q1, down -1.35% from previous quarter.
  • Nuvation Bio Inc. reported quarterly total assets of 621.48 Million USD for 2023 Q4, down -1.49% from previous quarter.

Annual Total Assets Chart of Nuvation Bio Inc. (2023 - 2018)

Historical Annual Total Assets of Nuvation Bio Inc. (2023 - 2018)

Year Total Assets Total Assets Growth
2023 621.48 Million USD -7.54%
2022 672.14 Million USD -13.4%
2021 776.15 Million USD 249.95%
2020 221.79 Million USD 83.37%
2019 120.95 Million USD 76451.9%
2018 158 Thousand USD 0.0%

Peer Total Assets Comparison of Nuvation Bio Inc.

Name Total Assets Total Assets Difference
ADC Therapeutics SA 354.78 Million USD -75.173%
Alto Neuroscience, Inc. 86.62 Million USD -617.417%
Annovis Bio, Inc. 10.2 Million USD -5988.048%
Biohaven Pharmaceutical Holding Company Ltd. 513.21 Million USD -21.097%
Ginkgo Bioworks Holdings, Inc. 1.66 Billion USD 62.681%
Nuvation Bio Inc. 621.48 Million USD 0.0%
Arcus Biosciences, Inc. 1.09 Billion USD 43.243%
Theriva Biologics, Inc. 60.21 Million USD -932.177%
Zymeworks Inc. 580.88 Million USD -6.99%